Linezolid som behandling af infektiøs endokarditis

Trine Kiilerich Lauridsen; Magnus Arpi; Niels Eske Bruun

Linezolid som behandling af infektiøs endokarditis

Trine Kiilerich Lauridsen, Magnus Arpi, Niels Eske Bruun

Institut for Klinisk Medicin

1 Citationer (Scopus)

Abstract

In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.

Bidragets oversatte titel	[Linezolid therapy for infectious endocarditis]
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	172
Udgave nummer	16
Sider (fra-til)	1215-6
Antal sider	2
ISSN	0041-5782
Status	Udgivet - 19 apr. 2010

Citationsformater

@article{7f900122f46e4edd850b4987a3beca60,

title = "Linezolid som behandling af infekti{\o}s endokarditis",

abstract = "In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.",

author = "Lauridsen, {Trine Kiilerich} and Magnus Arpi and Bruun, {Niels Eske}",

year = "2010",

month = apr,

day = "19",

language = "Dansk",

volume = "172",

pages = "1215--6",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "16",

}

TY - JOUR

T1 - Linezolid som behandling af infektiøs endokarditis

AU - Lauridsen, Trine Kiilerich

AU - Arpi, Magnus

AU - Bruun, Niels Eske

PY - 2010/4/19

Y1 - 2010/4/19

N2 - In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.

AB - In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 172

SP - 1215

EP - 1216

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 16

ER -

Linezolid som behandling af infektiøs endokarditis

Abstract

Fingeraftryk

Citationsformater